Novartis | رأس المال والاحتياطيات



Equity Capital And Reserves تغيير تاريخ
AbbVie USD 1.46B 1.86B 2025-03
Alcon AG USD 22.02B 466M 2025-03
Almirall EUR 1.46B 37.19M 2025-06
Amgen USD 6.21B 330M 2025-03
AstraZeneca USD 44.72B 3.68B 2025-06
Autolus Therapeutics Ltd 371.11M 56.22M 2025-03
Bayer EUR 32.58B 537M 2025-03
Biogen USD 17.63B 655.3M 2025-06
Bristol-Myers Squibb USD 17.49B 100M 2025-06
Eli Lilly USD 15.85B 1.65B 2025-03
Fresenius EUR 19.41B 135M 2025-03
Fresenius Medical Care EUR 15.5B 928.44M 2025-03
Galapagos EUR 2.64B 104.07M 2025-06
Genmab DKK 5.3B 31.4B 2025-03
Gilead Sciences USD 19.08B 252M 2025-03
GlaxoSmithKline GBP 14.35B 197M 2025-06
GRIFOLS EUR 7.6B 1.96B 2025-06
Hikma Pharmaceutical USD 2.32B 35M 2024-12
J&J USD 78.11B 6.62B 2025-03
Lonza CHF 9.33B 23M 2024-12
Merck EUR 29.9B 89M 2025-03
Merck USD 48.34B 2.02B 2025-03
Novartis USD 42.05B 3.6B 2025-06
Novartis USD 44.05B 729M 2024-12
Novo Nordisk 168.07B 29.53B 2025-06
Orion EUR 919.6M 147.2M 2025-06
Pfizer USD 88.7B 1.64B 2025-06
Philips EUR 10.38B 1.32B 2025-06
Recordati EUR 1.87B 107.18M 2025-06
Regeneron Pharmaceuticals USD 29.94B 551.3M 2025-06
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 70.28B 3.8B 2025-06
UCB EUR 10.03B 1.08B 2024-12


Novartis رأس المال والاحتياطيات - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Aug 2025.